Literature DB >> 1739180

Surgical treatment of primary carcinoma of the gallbladder based on the histologic analysis of 48 surgical specimens.

Y Matsumoto1, H Fujii, H Aoyama, M Yamamoto, K Sugahara, K Suda.   

Abstract

During the past 5 years, extended cholecystectomy and/or more radical procedures, including pancreatoduodenectomy and extended hepatic lobectomy, were performed on 48 patients with carcinoma of the gallbladder in an attempt to cure the disease. It was retrospectively proven from microscopic analysis of the surgical specimens taken from the 48 patients that 28 patients had received curative resections. The 28 consisted of all 4 patients with stage I carcinoma, all 9 with stage II, 6 of 8 with stage III, and 9 of 27 with stage IV. We reached the following conclusions: (1) extended cholecystectomy with resection of the bile duct in the hepatoduodenal ligament is the optimum procedure for patients with stage I and stage II carcinomas, and (2) for patients with stage III carcinoma, more radical procedures, including pancreatoduodenectomy and/or wider resection of the liver, might result in curative resection of the disease. For some patients with stage IV tumors, such as duodenal invasion or direct invasion of the liver, curative resection may be achieved by pancreatoduodenectomy or extended hepatic lobectomy.

Entities:  

Mesh:

Year:  1992        PMID: 1739180     DOI: 10.1016/0002-9610(92)90109-5

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  31 in total

1.  Surgery for gallbladder cancer: The need to generate greater evidence.

Authors:  Shailesh V Shrikhande; Savio G Barreto
Journal:  World J Gastrointest Surg       Date:  2009-11-30

2.  Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma.

Authors:  Woo Seok Kim; Dong Wook Choi; Dong Do You; Chuan Yu Ho; Jin Seok Heo; Seong Ho Choi
Journal:  J Gastrointest Surg       Date:  2010-01-22       Impact factor: 3.452

3.  Extra-Hepatic Bile Duct Resection: an Insight in the Management of Gallbladder Cancer.

Authors:  Durgatosh Pandey; Pankaj Kumar Garg; N M L Manjunath; Jyoti Sharma
Journal:  J Gastrointest Cancer       Date:  2015-09

4.  Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention.

Authors:  Y Fong; W Jarnagin; L H Blumgart
Journal:  Ann Surg       Date:  2000-10       Impact factor: 12.969

5.  Gallbladder carcinoma with biliary invasion: clinical analysis of the differences from nonbiliary invasion.

Authors:  Kun-Ming Chan; Ta-Sen Yeh; Ming-Chin Yu; Yi-Yin Jan; Tsann-Long Hwang; Miin-Fu Chen
Journal:  World J Surg       Date:  2005-01       Impact factor: 3.352

6.  Adjuvant chemoradiotherapy for squamous cell carcinoma of gallbladder.

Authors:  Supriya Mallick; Rony Benson; P K Julka; Goura Kishor Rath
Journal:  J Gastrointest Cancer       Date:  2014-12

Review 7.  Gall bladder carcinoma: Aggressive malignancy with protean loco-regional and distant spread.

Authors:  Amit Nandan Dhar Dwivedi; Shivi Jain; Ruhi Dixit
Journal:  World J Clin Cases       Date:  2015-03-16       Impact factor: 1.337

Review 8.  Candidate gene studies in gallbladder cancer: a systematic review and meta-analysis.

Authors:  Kshitij Srivastava; Anvesha Srivastava; Kiran Lata Sharma; Balraj Mittal
Journal:  Mutat Res       Date:  2011-06-25       Impact factor: 2.433

9.  Extent of resection for T2N0 gallbladder carcinoma regarding concurrent extrahepatic bile duct resection.

Authors:  Sung-Chan Gwark; Shin Hwang; Ki-Hun Kim; Yong-Joo Lee; Kwang-Min Park; Chul-Soo Ahn; Deok-Bog Moon; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Gil-Chun Park; Sung-Gyu Lee
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2012-11-30

Review 10.  Surgical management of gallbladder carcinoma: a review.

Authors:  Kristin L Mekeel; Alan W Hemming
Journal:  J Gastrointest Surg       Date:  2007-09       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.